3D QSAR Studies on Substituted Benzimidazole Derivatives as Angiotensin II-AT1 Receptor Antagonist

Publisher： Bentham Science Publishers

E-ISSN： 1875-6697|9|3|433-445

ISSN： 1573-4099

Source： Current Computer - Aided Drug Design, Vol.9, Iss.3, 2013-09, pp. : 433-445

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Substituted Benzimidazole Derivatives as Angiotensin II -AT1 Receptor Antagonist: A Review

By  

Mini Reviews in Medicinal Chemistry, Vol. 10, Iss. 14, 2010-12 ,pp. : 1366-1384

Bentham Science Publishers

Access to resources Recommend Favorite

Comparative Study of 3D-QSAR Techniques on Angiotensin II Receptor (AT1) Antagonists

By  

Letters in Drug Design & Discovery, Vol. 1, Iss. 2, 2004-04 ,pp. : 115-120

Bentham Science Publishers

Access to resources Recommend Favorite

Synthesis and angiotensin II receptor antagonist activity of C-linked pyrimidine derivatives

By Nicolai E.   Cure G.   Goyard J.   Kirchner M.   Teulon J.   Versigny A.   Cazes M.   Virone-Oddos A.   Caussade F.   Cloarec A.  

European Journal of Medicinal Chemistry, Vol. 30, Iss. 5, 1995-01 ,pp. : 365-375

Elsevier

Access to resources Recommend Favorite

Docking and 3D QSAR Studies on Substituted Cyclobutylphenyl Quinoline Derivatives as Inhibitors of Bacterial DNA Gyrase

By  

Current Computer - Aided Drug Design, Vol. 14, Iss. 4, 2018-12 ,pp. : 322-337

Bentham Science Publishers

Access to resources Recommend Favorite

Binding of the antagonist [ 3 H]candesartan to angiotensin II AT 1 receptor-tranfected Chinese hamster ovary cells

By Fierens F.   Vanderheyden P.M.L.   De Backer J.-P.   Vauquelin G.  

European Journal of Pharmacology, Vol. 367, Iss. 2, 1999-02 ,pp. : 413-422

Elsevier

Access to resources Recommend Favorite